UnknownNot applicableNCT02091505

Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO

Studying Central retinal vein occlusion

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mie University
Principal Investigator
Mineo Kondo, MD, PhD
Mie University Hospital
Intervention
Ranibizumab(drug)
Enrollment
30 enrolled
Eligibility
20-80 years · All sexes
Timeline
2013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02091505 on ClinicalTrials.gov

Other trials for Central retinal vein occlusion

Additional recruiting or active studies for the same condition.

See all trials for Central retinal vein occlusion

← Back to all trials